Table 4.
HRCT score versus change in pulmonary function after 24 weeks of therapy
| Somewhat worse | Same | Somewhat better | |
|---|---|---|---|
| Number of patients | 1 | 9 | 5 |
| FVC, L | −0.11 | −0.04a
(−0.28, 0.19) |
−0.11 (−0.19, 0.14) |
| FVC percent predicted, % | −3 | −1 (-9, 6) |
−2 (-5, 16) |
| FEV-1, L | −0.18 | −0.11 (−0.48, 0.13) |
−0.17 (−0.24, 0.07) |
| FEV-1 percent predicted, % | −7 | −1 (−17, 6) |
−3 (−10, 16) |
| FEV1/FVC ratio, % | −0.04 | −0.01 (−0.31, 0.04) |
−0.02 (−0.09, 0.031) |
| DLCO, mL CO (STPD)/min/mmHg | 1.17 | −0.22 (−5.01, 6.28) |
2.905 (−1.66. 3.8) |
| DLCO percent predicted, %b | 10 | 4 (−14, 26) |
16.5 (11, 27) |
| 6-min walk distance, m | 0 | −3.81 (−137, 297) |
61.9 (0, 260) |
aMedian (range)
bSignificantly different from same, p = 0.0308